Research output: Contribution to journal › Article › peer-review
Atorvastatin calcium inclusion complexation with polysaccharide arabinogalactan and saponin disodium glycyrrhizate for increasing of solubility and bioavailability. / Kong, Ruiping; Zhu, Xingyi; Meteleva, Elizaveta S. et al.
In: Drug Delivery and Translational Research, Vol. 8, No. 5, 01.10.2018, p. 1200-1213.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Atorvastatin calcium inclusion complexation with polysaccharide arabinogalactan and saponin disodium glycyrrhizate for increasing of solubility and bioavailability
AU - Kong, Ruiping
AU - Zhu, Xingyi
AU - Meteleva, Elizaveta S.
AU - Polyakov, Nikolay E.
AU - Khvostov, Mikhail V.
AU - Baev, Dmitry S.
AU - Tolstikova, Tatjana G.
AU - Dushkin, Alexander V.
AU - Su, Weike
PY - 2018/10/1
Y1 - 2018/10/1
N2 - The aim of the present investigation was to enhance the solubility and dissolution of atorvastatin calcium (ATV), a poorly water-soluble drug with larch polysaccharide arabinogalactan (AG) and disodium glycyrrhizate (Na2GA) as carriers of drug delivery systems for improving its bioavailability. The interactions of ATV with AG or Na2GA were investigated by DSC, XRD, SEM, and NMR techniques. The molecular weights of supramolecular systems—inclusion complexes and micelles—which are the hosts for ATV molecules were measured. On the other hand, the rapid storage assay (+ 40 °C for 3 months) showed that the chemical stability of ATV/AG and ATV/Na2GA complexes had been enhanced compared with pure ATV. In vitro drug release showed a significant increase in ATV’s dissolution rate after formation of a complex with Na2GA or AG. Pharmacokinetic tests in vivo on laboratory animals showed a significant increase in ATV’s bioavailability after its introduction as a complex with Na2GA or AG. Moreover, ATV/AG and ATV/Na2GA complexes showed a more prominent decrease of total cholesterol (TC) level compared to net ATV. Therefore, the novel mechanochemically synthesized complexes of ATV with AG or Na2GA as drug delivery systems might be potential and promising candidates for hypercholesterolemia treatment and deserved further researches.
AB - The aim of the present investigation was to enhance the solubility and dissolution of atorvastatin calcium (ATV), a poorly water-soluble drug with larch polysaccharide arabinogalactan (AG) and disodium glycyrrhizate (Na2GA) as carriers of drug delivery systems for improving its bioavailability. The interactions of ATV with AG or Na2GA were investigated by DSC, XRD, SEM, and NMR techniques. The molecular weights of supramolecular systems—inclusion complexes and micelles—which are the hosts for ATV molecules were measured. On the other hand, the rapid storage assay (+ 40 °C for 3 months) showed that the chemical stability of ATV/AG and ATV/Na2GA complexes had been enhanced compared with pure ATV. In vitro drug release showed a significant increase in ATV’s dissolution rate after formation of a complex with Na2GA or AG. Pharmacokinetic tests in vivo on laboratory animals showed a significant increase in ATV’s bioavailability after its introduction as a complex with Na2GA or AG. Moreover, ATV/AG and ATV/Na2GA complexes showed a more prominent decrease of total cholesterol (TC) level compared to net ATV. Therefore, the novel mechanochemically synthesized complexes of ATV with AG or Na2GA as drug delivery systems might be potential and promising candidates for hypercholesterolemia treatment and deserved further researches.
KW - Arabinogalactan
KW - Atorvastatin calcium
KW - Disodium glycyrrhizin
KW - Mechanochemistry
KW - Solubility
KW - Supramolecular complexes
KW - ACID MICELLES
KW - ENHANCED BIOAVAILABILITY
KW - MECHANOCHEMICAL PREPARATION
KW - SOLUBLE INTERMOLECULAR COMPLEXES
KW - PHYSICOCHEMICAL PROPERTIES
KW - SOLID DISPERSIONS
KW - ORAL BIOAVAILABILITY
KW - BETA-CYCLODEXTRIN
KW - IN-VIVO EVALUATION
KW - DISSOLUTION RATE
UR - http://www.scopus.com/inward/record.url?scp=85052281627&partnerID=8YFLogxK
U2 - 10.1007/s13346-018-0565-x
DO - 10.1007/s13346-018-0565-x
M3 - Article
C2 - 30039497
AN - SCOPUS:85052281627
VL - 8
SP - 1200
EP - 1213
JO - Drug Delivery and Translational Research
JF - Drug Delivery and Translational Research
SN - 2190-393X
IS - 5
ER -
ID: 16246430